Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer
Ace Vision Group announced that it has named Val Kolesnitchenko, MD, as Chief Scientific Officer.
Dr. Kolesnitchenko has served in leadership roles for three decades in clinical ophthalmology practice and industry. Most recently, he held the position of Executive Director of Global Scientific Affairs at Bausch + Lomb, overseeing the medical and clinical development of the company’s surgical portfolio.
Explore More Articles
VIDEO: New laser offers further improvement to laser scleral microporation
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, AnnMarie Hipsley, DPT, PhD, and George O. Waring IV, MD, FACS, discuss the latest advances in laser scleral microporation.Hipsley said that the GenII VisioLite laser for laser scleral microporation (LSM) is on the pathway to commercialization and may be available by the end of the year.
read moreLaser scleral microporation helps turn back the clock for presbyopic eyes
VIENNA — In this Healio Video Perspective from the ESCRS meeting, Robert Ang, MD, shares his results with laser scleral microporation for the treatment of presbyopia. He explains the rationale of laser scleral microporation (Ace Vision Group), how it is performed, and the advantages of a treatment that does not interfere with the visual axis and allows the …
read moreTreatment landscape for presbyopia evolving toward noninvasive options
Noninvasive or minimally invasive approaches may be the solution for presbyopia before the onset of age-related cataract and a way to address the increasing need to perform close-range tasks. “The treatments that are currently available have not met our needs,” OSN Cornea/External Disease Board Member Eric D. Donnenfeld, MD, said. “Glasses are an inconvenience. Contact lenses cause …
read more